Alembic Pharma gets USFDA nod for Alembic Pharma

The approved product is therapeutically equivalent to AstraZeneca Pharmaceuticals' Xylocaine ointment, 5 per cent.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SdC3oq
via IFTTT

0 comments:

Post a Comment